Nebenwirkungen · Avastin
Avastin 25 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 11
HOS-113549 · Präparat HOS-093945
Table 1 provides all adverse reactions by frequency that were determined to have a causal relationship with Avastin through: • comparative incidences noted between clinical trial treatment arms (with at least a 10% difference compared to the control arm for NCI-CTCAE Grade 1-5 reactions or at least a 2% difference compared to the control arm for NCI-CTCAE Grade 3-5 reactions, • post-authorisation safety studies, • spontaneous reporting, • epidemiological studies\non-interventional or observational studies, • or through an evaluation of individual case reports.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-27T12:02:00Z · SHA-256 66d06bf8e8d4853783377bc4046bd6b4b0e313cc348c230743646f93a9381bb1 · Passage e0e1c84c625ad56c595d934227319a2859e78fcb12d836e7b041b40ad18070db · Zeichen 1409–2007 im Abschnitt